SMS Pharmaceuticals

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue151.01150.69135.85167.45162.97
Expenses144.60140.04122.69152.29146.56
EBITDA20.4724.5027.1728.6330.37
EBIT12.3616.5319.4820.7322.36
Profit Before Tax6.4210.6413.1515.1616.41
Net Profit5.038.079.2812.0512.17
Financial Ratios
Operating Profit Margin13.76%16.40%20.08%17.18%18.81%
Net Profit Margin3.38%5.40%6.86%7.23%7.54%
Earning Per Share (Diluted)0.590.951.101.421.44
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.7
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ